I currently don't have live access to the latest feeds. I'll summarize the most recent publicly reported antidepressant recalls up to my last update and suggest how to verify current status.Here’s a concise update on recent antidepressant recalls and how to verify the latest information.
What’s been reported most recently
- Duloxetine recalls (Cymbalta): Multiple outlets in late 2024 reported recalls of delayed-release duloxetine capsules (20 mg) due to nitrosamine impurities that could pose cancer risk with long-term exposure. The recall affected thousands of bottles distributed in the US, with batch specifics including expiration around December 2024 and lot numbers like 220, issued by manufacturers such as Towa Pharmaceutical Europe and Breckenridge Pharmaceutical, Inc. This recall was described as voluntary and tied to FDA safety guidance.[1][4][5]
- UK MHRA activity in 2026: In April 2026, the UK Medicines and Healthcare products Regulatory Agency (MHRA) issued precautionary recalls of a widely prescribed antidepressant after packaging errors led to wrong-drug contents in a batch. This highlights ongoing manufacturing checks and recalls for antidepressants in the UK.[6][8][9]
Notes on what to look for if you’re checking your meds
- If you’re in the US and use duloxetine: check your bottle for the recall lot number and expiration date referenced in FDA recall notices (often 20 mg delayed-release capsules, lot specifics like 220128 with expiration December 2024). Do not stop taking a prescribed antidepressant abruptly; contact your prescriber if your bottle is affected.[4][5]
- If you’re in the UK or Europe: monitor MHRA announcements for any precautionary recalls or manufacturing issues tied to your antidepressant lot, and follow guidance from healthcare professionals on returning stock or seeking alternatives.[8][9][6]
How to verify current status
- Check official sources:
- U.S. FDA recall notices for duloxetine and other antidepressants, including lot numbers, expiration dates, and disposal guidance.[4]
- MHRA updates and recalls in the UK, including batch-specific details and manufacturer responses.[9][6]
- If your prescription isn’t clearly covered by a public recall notice, contact your pharmacist or prescriber with:
- Medication name and strength
- Batch/lot code and expiration
- Your purchase/dispense date
Illustrative example
- If you have a bottle of duloxetine 20 mg delayed-release capsules, check the lot number on the bottle against FDA recall postings (e.g., lot 220128 with a December 2024 expiration). If it matches, follow the recall instructions (return or contact your pharmacist) and do not stop taking it without medical advice.[5][4]
Would you like me to pull the latest official recall notices for a specific country (e.g., UK or US) and provide direct links and steps to verify your specific batch? I can also help you search for the exact lot numbers you have.
Sources
The Medicines and Healthcare products Regulatory Agency (MHRA) has recalled a batch of a commonly prescribed antidepressant as a precautionary measure after an error at the manufacturing site led to the wrong drug being included in a pack. In a class two recall notice published on 28 April 2026, the MHRA said that a pack of […]
pharmaceutical-journal.comBy Children’s Health Defense Team
publichealthpolicyjournal.comOver 7,100 bottles of duloxetine are part of the recall, according to the FDA.
abcnews.comThe UK health watchdog MHRA issued a recall for a commonly prescribed antidepressant across the UK.The recall comes after a patient found the wrong drug inside their sealed packaging.More than 80,000 packs of a popular...
www.geo.tvThe Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain cancer-causing chemicals.
en.as.comThe Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
childrenshealthdefense.orgThe MHRA has advised healthcare professionals to stop supplying the affected batch of Sertraline 100mg and return all remaining stock to their suppliers.
www.gov.ukThe FDA recalled delayed-release capsules of duloxetine because they potentially contain nitrosamine impurities, which can be harmful with too much exposure.
www.cnet.com